Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

Abstract Most soft-tissue sarcomas (STS) exhibit an immunosuppressive tumor microenvironment (TME), leading to resistance against immune checkpoint inhibitors (ICIs) and limited therapeutic response. Preclinical data suggest that oncolytic viral therapy can remodel the TME, facilitating T cell accum...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, Florent Peyraud, Michèle Kind, Lucile Vanhersecke, François Le Loarer, Raul Perret, Coralie Cantarel, Carine Bellera, Alban Bessede, Antoine Italiano
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-02-01
Col·lecció:	Molecular Cancer
Matèries:	Soft-tissue sarcoma Oncolytic virus JX-594 Low-dose cyclophosphamide Avelumab
Accés en línia:	https://doi.org/10.1186/s12943-024-01946-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!